Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
- DOI
- 10.1016/j.ahj.2009.07.035
- Published
- 2010 Mar
- Container
- American heart journal
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ahj.2009.07.035,
title = {Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.},
author = {Lopes RD and Alexander JH and Al-Khatib SM and Ansell J and Diaz R and Easton JD and Gersh BJ and Granger CB and Hanna M and Horowitz J and Hylek EM and McMurray JJ and Verheugt FW and Wallentin L and ARISTOTLE Investigators},
year = {2010},
journal = {American heart journal},
doi = {10.1016/j.ahj.2009.07.035},
url = {https://doi.org/10.1016/j.ahj.2009.07.035}
}RIS
TY - JOUR TI - Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. AU - Lopes RD AU - Alexander JH AU - Al-Khatib SM AU - Ansell J AU - Diaz R AU - Easton JD AU - Gersh BJ AU - Granger CB AU - Hanna M AU - Horowitz J AU - Hylek EM AU - McMurray JJ AU - Verheugt FW AU - Wallentin L AU - ARISTOTLE Investigators PY - 2010 JO - American heart journal DO - 10.1016/j.ahj.2009.07.035 UR - https://doi.org/10.1016/j.ahj.2009.07.035 ER -
APA
RD, L., JH, A., SM, A., J, A., R, D., JD, E., BJ, G., CB, G., M, H., J, H., EM, H., JJ, M., FW, V., L, W., & Investigators, A. (2010). Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.. American heart journal. https://doi.org/10.1016/j.ahj.2009.07.035
Source records
- pubmed · retrieved 2026-09-25T20:58:45.096Z